Register for the OnDemand Emerging Topic Conference: Multi-Omics Approaches for Cholestatic Liver Diseases!
Learn how multi-omics approaches can be a tool to understand, diagnose and to develop future treatments for cholestatic liver diseases. Register today for the 2023 OnDemand Emerging Topic Conference: Multi-Omics Approaches for Cholestatic Liver Diseases: From Diagnosis to Disease Mechanisms and Precision Medicine happening June 1-2 online.
During this two-day event, attendees will view OnDemand presentations and network directly with experts in a virtual environment.
HOW IT WORKS
June 1: Day one is an immersive experience in education around multi-omics that will address the contribution of multi-omics approaches to new liver biology knowledge and care of patients with a variety of chronic liver diseases.
Learn about advances to improve the understanding, diagnosis and treatment of liver diseases, including:
- Recent advances in “omics” technologies (i.e., genomic, proteomics, metabolomics) as applied to cholangiopathies and cholestatic liver diseases.
- The crucial role of the microbiome and the environment in biliary diseases.
- Innovations in computational tools for large scale data integration.
- The use of human stem cell-based cell models (i.e., induced pluripotent stem cells (iPSCs) and 3D-organoids) as a complementary tool for precision medicine.
June 2: On day two, attendees have a chance to join deeper discussions around the topics covered during day one. Attendees will network in virtual Zoom rooms, with speakers, our program chairs and other attendees.
When & Where
Date: Thursday, June 1, 8:00 am - Friday, June 2, 10:00 am (EDT) Location: Online
- To provide an overview of the current advances in multi-omics technologies and their contribution to the understanding, diagnosis and treatment of cholestatic liver diseases.
- To recognize the importance of stem-cell based human disease models and of organoids as a tool for functional validation of multi-omics data and to advance personalized medicine approaches for rare liver diseases.
- To identify current knowledge gaps and limitations for the introduction of these technologies in clinical practice.
- Fellows/ Trainees
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AASLD designates this live activity for a maximum of 8.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Agenda - June 1, 2023
15 mins Welcome and Course Objectives
Romina Fiorotto, PhD
45 mins Biliary Diseases: What Are the Missing Pieces?
Mario Strazzabosco, MD, PhD, FAASLD
Session I: Genomics
20 mins Cholestatic Liver Diseases: Harnessing the Genetics and Epigenetics
Gideon Hirschfield, FRCP, PhD
20 mins Next Generation Sequencing for Diagnosis of Infantile Cholestatic Diseases
Richard Thompson, MD, PhD, FAASLD
20 mins The Transcriptomic of Biliary Atresia
Alexander Miethke, MD
20 mins Liver Disease Immunophenotyping: When a Single Cell Matter
Sonya MacParland, PhD
Session II: Proteomics and Metabolomics
20 mins Ig Glycosylation in Autoimmune Cholangitis
Xing Zhou, MD
20 mins Multispectral Imaging for In-situ Analysis of Hepatic Immune Cells in Chronic Liver Diseases
Heather L. Stevenson-Lerner, MD, PhD
20 mins Serum Proteome for the Discovery of Biomarkers
Pedro Rodrigues, PhD
20 mins FDA Perspective on Analytic Platforms for Biomarkers
Robert Schuck, PharmD, PhD
Session III: Microbiome
20 mins Considerations when Designing a Human Microbiome Study
Debbie Shawcross, PhD, MBBS, MRCP
20 mins Bile Microbiome and Autoimmune Liver Diseases
Christoph Schramm, MD
20 mins Microbiome-immune System Cross-talk in Cholestatic Diseases
Naiara Beraza, MD
20 mins Microbiome-based Therapeutics
Jasmohan Bajaj, MD
Session IV: The Synergism Between Big Data and Disease Modeling
20 mins Stem Cell-based in Vitro Systems to Model Liver Diseases and Multi-omic Analysis
Romina Fiorotto, PhD
20 mins How Can Large Databases Address the Challenges of Rare Diseases?
Binita M. Kamath, MBBChir
20 mins Personalized Medicine from Clinical Biospecimens
David N. Assis, MD
Session V: Multi Omics Integration
20 mins A Multiomic Approach to Biological and Environmental Pertubations
Erin S. Baker, PhD
20 mins Studying Exposome in PSC
Konstantinos N. Lazaridis, MD, FAASLD
20 mins Applying Artificial Intelligence (AI) in Cholestatic Liver Diseases
Dennis Shung, MD
20 mins Bench to Bedside: How Can Omics be Translated into Clinic
Tom H. Karlsen, MD, PhD
10 mins Closing Remarks
Nidhi Jalan-Sakrikar, PhD
Agenda - June 2, 2023
Live Meet-The-Expert Roundtable Discussions
10:00 - 10:30 AM
Session 1 Genomics Roundtable
Moderated by: Nanda Kerkar, MD, FAASLD
10:30 - 11:00 AM
Session 2 Proteomics and Metabolomics Roundtable
Moderated by: Nisanne S. Ghonem, PhD
11:00 – 11: 30 AM
Session 3 Microbiome Roundtable
Moderated by: Romina Fiorotto, PhD
11:30 AM – 12:00 PM
Session 4 The Synergism Between Big Data and Disease Modeling Roundtable
Moderated by: Nidhi Jalan-Sakrikar, PhD
12:00 – 12:30 PM
Session 5 Multi Omics Integration Roundtable
Moderated by: Christopher L. Bowlus
General, Trainee, Associate and Student
General: Any physician, scientist, or researcher with doctoral-level training who is not employed by Industry (pharma/device/etc.)
Trainee & Associate: Any physician, scientist or researcher in a training program as certified by the director of their training program. This category also includes, but is not limited to, the degrees of MS, NP, PA, RN, and other related or comparable degrees.
Industry: Any Industry (pharma/device/etc.) employee with or without medical training.
|On or before May 21, 2023||Member||Non-Member|
|Trainee & Associate||$195||$245|
Any Industry (pharma/device/etc.) employee with or without medical training.
|On or before May 21, 2023||$775|
Registration Cancellation Policy
Requests for cancellation must be submitted in writing to firstname.lastname@example.org.
• through May 21, 2023 at 11:59PM are subject to a 25% cancellation fee.
• from May 22, 2023 and after are non-refundable.